206 related articles for article (PubMed ID: 26275864)
1. Diabetes mellitus and cancer of the digestive organs: An Italian population-based cohort study.
Valent F
J Diabetes Complications; 2015; 29(8):1056-61. PubMed ID: 26275864
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
3. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort.
Romon I; Rey G; Mandereau-Bruno L; Weill A; Jougla E; Eschwège E; Simon D; Druet C; Fagot-Campagna A
Diabet Med; 2014 Aug; 31(8):946-53. PubMed ID: 24627972
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism and risk of cancer in patients with diabetes mellitus.
Christensen DH; Horváth-Puhó E; Thomsen RW; Knudsen ST; Dekkers O; Prandoni P; Sørensen HT
J Diabetes Complications; 2016; 30(4):603-7. PubMed ID: 26874682
[TBL] [Abstract][Full Text] [Related]
5. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
Knapen LM; van Dalem J; Keulemans YC; van Erp NP; Bazelier MT; De Bruin ML; Leufkens HG; Croes S; Neef C; de Vries F; Driessen JH
Diabetes Obes Metab; 2016 Mar; 18(3):258-65. PubMed ID: 26537555
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and cancer risk in a network of case-control studies.
Bosetti C; Rosato V; Polesel J; Levi F; Talamini R; Montella M; Negri E; Tavani A; Zucchetto A; Franceschi S; Corrao G; La Vecchia C
Nutr Cancer; 2012; 64(5):643-51. PubMed ID: 22519904
[TBL] [Abstract][Full Text] [Related]
7. Association of Physical Activity by Type and Intensity With Digestive System Cancer Risk.
Keum N; Bao Y; Smith-Warner SA; Orav J; Wu K; Fuchs CS; Giovannucci EL
JAMA Oncol; 2016 Sep; 2(9):1146-53. PubMed ID: 27196375
[TBL] [Abstract][Full Text] [Related]
8. [Incidence and prevalence of digestive system tumors: data from Italian tumor registries].
Micheli A; Zanetti R
Ann Ist Super Sanita; 1996; 32(4):503-12. PubMed ID: 9382421
[TBL] [Abstract][Full Text] [Related]
9. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
12. Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy.
Gini A; Bidoli E; Zanier L; Clagnan E; Zanette G; Gobbato M; De Paoli P; Serraino D
Cancer Epidemiol; 2016 Apr; 41():80-7. PubMed ID: 26851751
[TBL] [Abstract][Full Text] [Related]
13. [Digestive cancers in France. Geographic distribution and estimation of national incidence].
Faivre J; Grosclaude P; Launoy G; Arveux P; Raverdy N; Menegoz F; Pienkowski P; Schaffer P; Daures JP; De Vathaire F
Gastroenterol Clin Biol; 1997; 21(3):174-80. PubMed ID: 9161491
[TBL] [Abstract][Full Text] [Related]
14. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk.
Brodovicz KG; Kou TD; Alexander CM; O'Neill EA; Engel SS; Girman CJ; Goldstein BJ
Diabetes Obes Metab; 2012 Dec; 14(12):1123-8. PubMed ID: 22831166
[TBL] [Abstract][Full Text] [Related]
16. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
17. Awareness of albuminuria in an Italian population-based cohort of patients treated with hypoglycemic drugs.
Degli Esposti L; Saragoni S; Buda S; Sturani A; Quintaliani G; Bartolucci S; Di Turi R; Lilli P; Didoni G; Degli Esposti E
J Nephrol; 2012; 25(3):325-31. PubMed ID: 21748718
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
Girelli CM; Reguzzoni G; Limido E; Savastano A; Rocca F
Recenti Prog Med; 1995 Apr; 86(4):143-6. PubMed ID: 7617956
[TBL] [Abstract][Full Text] [Related]
19. Upper gastrointestinal tract cancers: oesophagus, stomach, liver, gallbladder and biliary ducts, pancreas.
Ferretti S; Gafà L
Epidemiol Prev; 2004; 28(2 Suppl):34-42. PubMed ID: 15281604
[TBL] [Abstract][Full Text] [Related]
20. Second cancer following cancer of the digestive system in Connecticut, 1935-82.
Hoar SK; Wilson J; Blot WJ; McLaughlin JK; Winn DM; Kantor AF
Natl Cancer Inst Monogr; 1985 Dec; 68():49-82. PubMed ID: 4088313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
